Compare GNTA & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNTA | HERZ |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 28.3M |
| IPO Year | N/A | N/A |
| Metric | GNTA | HERZ |
|---|---|---|
| Price | $1.00 | $16.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 625.8K | 39.8K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $1.62 |
| 52 Week High | $10.00 | $19.30 |
| Indicator | GNTA | HERZ |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 82.02 |
| Support Level | $0.71 | $2.16 |
| Resistance Level | $1.70 | $19.30 |
| Average True Range (ATR) | 0.11 | 0.73 |
| MACD | 0.03 | 0.60 |
| Stochastic Oscillator | 85.53 | 84.16 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.